Clinical trial
Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)
NCT07579962 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)
- Lead sponsor
- Institute of Oncology Ljubljana
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 10, 2026
- Completion date
- June 30, 2032
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.